Please assess the completion status of the following clinical trial:

Trial Title: Transplantation of Cultured Gut Microflora to Repeat Antibiotic-induced Diarrhea Due to Clostridium Difficile

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Antibiotic-induced diarrhea~* Positive fecal analysis for Clostridium difficile toxin~Exclusion Criteria:~* Antibiotic treatment~* Probiotic treatment~* Intestinal infection other than Clostridium difficile~* Inflammatory bowel disease (Ulcerative colitis, Crohn's disease~* Immunodeficiency (drug- och disease-related)~* Pregnancy~* Unable to accept endoscopic procedures~* Unable to give informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Vancomycin (Type: ACTIVE_COMPARATOR): Secondary treatment for relapse of Clostridium difficile infection.
- Cultured human intestinal microbiota1 (Type: EXPERIMENTAL): Cultured intestinal microbiota is experimental treatment for relapse of Clostridium difficile infection.
- Cultured human intestinal microbiota2 (Type: EXPERIMENTAL): Cultured intestinal microbiota is thirdly experimental treatment for second relapse of Clostridium difficile infection.

Based on this trial design, predict the completion outcome and termination type (if applicable).